Cargando…

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy

Pharmacological conditioning aims to protect the heart from myocardial ischemia-reperfusion injury (IRI). Despite extensive research in this area, today, a significant gap remains between experimental findings and clinical practice. This review provides an update on recent developments in pharmacolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qian, Zuurbier, Coert J., Huhn, Ragnar, Torregroza, Carolin, Hollmann, Markus W., Preckel, Benedikt, van den Brom, Charissa E., Weber, Nina C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217104/ https://www.ncbi.nlm.nih.gov/pubmed/37408266 http://dx.doi.org/10.3390/cells12101432

Ejemplares similares

Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications
por: Roth, Sebastian, et al.
Publicado: (2021)

Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury
por: Stroethoff, Martin, et al.
Publicado: (2019)

A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients
por: Nederlof, Rianne, et al.
Publicado: (2017)

Cardioprotective Properties of Mannitol—Involvement of Mitochondrial Potassium Channels
por: Feige, Katharina, et al.
Publicado: (2021)

Mediation of the Cardioprotective Effects of Mannitol Discovered, with Refutation of Common Protein Kinases
por: Torregroza, Carolin, et al.
Publicado: (2021)

Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles
por: Feige, Katharina, et al.
Publicado: (2020)

Influence of Hyperglycemia and Diabetes on Cardioprotection by Humoral Factors Released after Remote Ischemic Preconditioning (RIPC)
por: Torregroza, Carolin, et al.
Publicado: (2021)

Influence of Hyperglycemia on Dexmedetomidine-Induced Cardioprotection in the Isolated Perfused Rat Heart
por: Torregroza, Carolin, et al.
Publicado: (2020)

Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia
por: Torregroza, Carolin, et al.
Publicado: (2021)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

Cardioprotective efficacy depends critically on pharmacological dose, duration of ischaemia, health status of animals and choice of anaesthetic regimen: a case study with folic acid
por: Zuurbier, Coert J, et al.
Publicado: (2014)

The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
por: Stroethoff, Martin, et al.
Publicado: (2020)

Activation of PKG and Akt Is Required for Cardioprotection by Ramelteon-Induced Preconditioning and Is Located Upstream of mKCa-Channels
por: Torregroza, Carolin, et al.
Publicado: (2020)

Remote Ischemic Conditioning to Protect against Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis
por: Brevoord, Daniel, et al.
Publicado: (2012)

Impact of Anesthetics on Cardioprotection Induced by Pharmacological Preconditioning
por: Bunte, Sebastian, et al.
Publicado: (2019)

Cardioprotective Properties of Humoral Factors Released after Remote Ischemic Preconditioning in CABG Patients with Propofol-Free Anesthesia—A Translational Approach from Bedside to Bench
por: Feige, Katharina, et al.
Publicado: (2022)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Milrinone-Induced Pharmacological Preconditioning in Cardioprotection: Hints for a Role of Mitochondrial Mechanisms
por: Raupach, Annika, et al.
Publicado: (2019)

Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
por: Feige, Katharina, et al.
Publicado: (2022)

Morphine induces preconditioning via activation of mitochondrial K(Ca) channels
por: Fräßdorf, Jan, et al.
Publicado: (2010)

Role of Endogenous Opioid System in Ischemic-Induced Late Preconditioning
por: Fraessdorf, Jan, et al.
Publicado: (2015)

Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
por: Li, Xiaoling, et al.
Publicado: (2021)

Perioperative Kardioprotektion – „From bench to bedside“: Aktuelle experimentelle Evidenz und mögliche Gründe für die limitierte Translation in die klinische Praxis
por: Torregroza, Carolin, et al.
Publicado: (2021)

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
por: Uthman, Laween, et al.
Publicado: (2020)

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
por: Xiao, Yang, et al.
Publicado: (2021)

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart
por: Zhang, Hong, et al.
Publicado: (2020)

Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia–induced cell damage
por: Weber, Nina C., et al.
Publicado: (2015)

Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1
por: Smit, Kirsten F., et al.
Publicado: (2018)

Prolonged Helium Postconditioning Protocols during Early Reperfusion Do Not Induce Cardioprotection in the Rat Heart In Vivo: Role of Inflammatory Cytokines
por: Oei, Gezina Tanya Mei Ling, et al.
Publicado: (2015)

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
por: Xiao, Yang, et al.
Publicado: (2021)

Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart
por: Nederlof, Rianne, et al.
Publicado: (2017)

Direct cardiac effects of SGLT2 inhibitors
por: Chen, Sha, et al.
Publicado: (2022)

Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury
por: Prag, Hiran A., et al.
Publicado: (2022)

Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2020)

Partial hexokinase II knockout results in acute ischemia–reperfusion damage in skeletal muscle of male, but not female, mice
por: Smeele, Kirsten M., et al.
Publicado: (2010)

Impact of Mitochondrial Ca(2+)-Sensitive Potassium (mBK(Ca)) Channels in Sildenafil-Induced Cardioprotection in Rats
por: Behmenburg, Friederike, et al.
Publicado: (2015)

Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats
por: Seefeldt, Jacob Marthinsen, et al.
Publicado: (2021)

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
por: Sahin, Mazlum, et al.
Publicado: (2022)

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
por: Lecour, Sandrine, et al.
Publicado: (2021)

Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion Injury
por: Chen, Yi-Wen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qd2712bmufm3uf4oa1fqk44psa